Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LBRX compared with AVTX: revenue, margins and what each company keeps, and the suppliers and customers both name
LBRX
LB Pharmaceuticals Inc
Change
Mkt cap
Revenue
Revenue
AVTX
Avalo Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LBRX
LB Pharmaceuticals Inc
vs
AVTX
Avalo Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LBRX
0
None
Shared
0
No disclosed counterparties: LBRX.
Only AVTX
5
LLY
Eli Lilly
supplier
JNJ
Janssen Pharmaceutics, Inc., now Johnson & Johnson Innovative Medicine ("J&J")
customer
—
Leap Therapeutics
unlisted
supplier
—
AlmataBio
unlisted
supplier
1 more · AVTX chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
LBRX
LB Pharmaceuticals Inc
Change
42.14
▲
+10.63%
· post 41.17
Mkt cap
$1.3B
Revenue
—
AVTX
Avalo Therapeutics, Inc.
Change
6.95
▲
+4.87%
· post 6.95
Closed
Nov 6 '26
Mkt cap
$383.4M
Revenue
$59,000
Q4 FY25
vs
Compare
Closed
Nov 6 '26
LBRX
LB Pharmaceuticals Inc
vs
AVTX
Avalo Therapeutics, Inc.
42.14
▲
+10.63%
post 41.17
Price
6.95
▲
+4.87%
post 6.95
$1.3B
Mkt cap
$383.4M
—
Revenue
$59,000
Q4 FY25
Change
Change
LBRX
42.14
▲
+10.63%
vs
AVTX
6.95
▲
+4.87%
Closed
Nov 6 '26